@JetBlue telling everyone in groups C,D,E, and F on a direct flight across the country that they have to check their carryon and then changing your mind after the first half of group C and having later groups get bags is ridiculous. Where is your customer loyalty?
𝖡𝗋𝖾𝖺𝗄 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝖢𝖺𝗇𝖼𝖾𝗋 and our president Tyler Jacks are featured in @TheCancerLetter today.
The story highlights our model of Radical Collaboration™ and how we’re aligning institutions and scientists to accelerate progress against the deadliest cancers.
https://t.co/KbQsCoHDSU
Five years ago, we asked:
What would cancer research look like if collaboration was built into the design?
#RadicalCollaboration™ is our answer.
These numbers reflect the scale
We can only stop cancer from recurring if we know it's there and treat it!
New Study Finds Hidden Disease in Nearly Half of Ovarian Cancer Patients in 'Remission' https://t.co/1n460WHcys
1/ Out today in @Cancer_Cell our work on spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts (CAFs)! Led by the brilliant @liuyunho with key contributions from @Aiims1742@humam_kadara and many collaborators @MDAndersonNews https://t.co/s84pbN84d1
Federal investment in science has helped make America great and now is NOT the time to retreat.
Progress against cancer and other diseases depends on collaboration—across institutions, disciplines, and funding sources. Public research funding, private philanthropy, and life sciences industry investments fuel transformative discoveries that save lives.
For decades, the U.S. has led the world in biomedical innovation, thanks in large part to federal research funding through agencies like the NIH and NCI. This funding has paved the way for groundbreaking advances in cancer treatment—from immunotherapies to precision medicine—while enabling the next generation of researchers to push the boundaries of what’s possible.
Cuts to federal research funding would put future progress at risk. Private foundations, like Break Through Cancer, play an important role in accelerating discovery, but we cannot do it alone. Without sustained public investment, clinical trials would slow, promising ideas would go unfunded, and lifesaving breakthroughs would be delayed.
We must work together to protect this vital investment. Share why research funding matters to you, and urge policymakers to keep driving progress forward. #FundResearch #ScienceMatters #StandUpForScience2025 #StandUpForScience
It's finally here! The last publication of my PhD was published today in Cell Genomics. Check out our hard work on prediction RNA Binding protein presence in human biofluid based on RNA! https://t.co/v16aeWIhqm #OpenAccess#Bioinformatics
My first, first author paper was published today! And with that I close the book on my graduate studies. So thankful for the help of my ragtag group of co-authors! @varduhip1@amilosav, Qizhi, Dongliang not on Twitter #PDAC#Bioinformatics
https://t.co/a5eKiINVN7
Terrific MD-PhD thesis defense from (soon to be) Dr Cathy Bradley I attended today has important implications for heterogeneity in mRNA vaccines, epitope broadening, and virus evolution @splon@bcmgenetics
Terrific MD-PhD thesis defense from (soon to be) Dr Cathy Bradley I attended today has important implications for heterogeneity in mRNA vaccines, epitope broadening, and virus evolution @splon@bcmgenetics
Cool paper by @varduhip1 on how lack of immune system determines which subtypes may engraft (and be studied) in #PDX models of #breastCancer#TNBC not included is similar preliminary data that #PDAC subtypes are likely the same
https://t.co/DDwsgdv17L
@factdude307@broadinstitute I'm excited for seasons again! Living in huit weather all year isn't exactly all it's cracked up to be 😬 should be getting there just in time for some awesome weather!
PhDone ✅ job ✅ Very excited to announce I passed my defense yesterday and accepted a position at the @broadinstitute data science platform starting next month! #BostonHereICome